Cargando…
Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome
SCYX-7158, an oxaborole, is currently in Phase I clinical trials for the treatment of human African trypanosomiasis. Here we investigate possible modes of action against Trypanosoma brucei using orthogonal chemo-proteomic and genomic approaches. SILAC-based proteomic studies using an oxaborole analo...
Autores principales: | Jones, Deuan C., Foth, Bernardo J., Urbaniak, Michael D., Patterson, Stephen, Ong, Han B., Berriman, Matthew, Fairlamb, Alan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689576/ https://www.ncbi.nlm.nih.gov/pubmed/26684831 http://dx.doi.org/10.1371/journal.pntd.0004299 |
Ejemplares similares
-
Chemical, genetic and structural assessment of pyridoxal kinase as a drug target in the African trypanosome
por: Jones, Deuan C, et al.
Publicado: (2012) -
Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome
por: Sharma, Amrita, et al.
Publicado: (2022) -
Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity
por: Gumbo, Maureen, et al.
Publicado: (2018) -
A transferrin receptor’s guide to African trypanosomes
por: Urbaniak, Michael D., et al.
Publicado: (2023) -
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)